Delta Asset Management LLC Eli Lilly & CO Transaction History

Delta Asset Management LLC

$1.16 Billion
Q3 2024

A detailed history of Delta Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Delta Asset Management LLC holds 731 shares of LLY stock, worth $561,232. This represents 0.06% of its overall portfolio holdings.

Number of Shares

731

Previous 723 1.11%

Holding current value

$561,232

Previous $654,000 1.07%

% of portfolio

0.06%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$772.14 - $960.02 $6,177 - $7,680	8 Added 1.11%	731 $647,000
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $15,397 - $20,599	-26 Reduced 3.47%	723 $562,000
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $2,100 - $2,476	4 Added 0.54%	749 $436,000
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $3,912 - $5,393	-9 Reduced 1.19%	745 $400,000
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $22,798 - $30,483	65 Added 9.43%	754 $353,000
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $21,433 - $25,172	-69 Reduced 9.1%	689 $236,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $8,038 - $9,366	25 Added 3.41%	758 $277,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $14,824 - $16,893	-50 Reduced 6.39%	733 $237,000
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $1,114 - $1,309	-4 Reduced 0.51%	783 $254,000
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $938 - $1,166	4 Added 0.51%	787 $225,000
Q2 2021 Aug 02, 2021	BUY	$180.55 - $233.54 $10,833 - $14,012	60 Added 8.3%	783 $180,000
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $3,410 - $4,104	-25 Reduced 3.34%	723 $119,000
Q1 2020 Apr 27, 2020	BUY	$119.05 - $147.35 $4,642 - $5,746	39 Added 5.5%	748 $104,000
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $8,767 - $10,859	82 Added 13.08%	709 $93,000
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $2,669 - $2,904	-25 Reduced 3.83%	627 $70,000
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $7,095 - $7,948	-67 Reduced 9.32%	652 $75,000
Q2 2018 Jul 23, 2018	BUY	$75.7 - $86.88 $2,422 - $2,780	32 Added 4.66%	719 $61,000
Q1 2018 Apr 26, 2018	SELL	$74.21 - $87.6 $4,823 - $5,694	-65 Reduced 8.64%	687 $53,000
Q4 2017 Jan 23, 2018	SELL	$81.94 - $87.89 $15,568 - $16,699	-190 Reduced 20.17%	752 $63,000
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $72,599 - $80,578	942	942 $81,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Asset Management LLC with notifications on news.

Account

Delta Asset Management LLC Eli Lilly & CO Transaction History